Intestinal IL-33 promotes microbiota-derived trimethylamine N -oxide synthesis and drives metabolic dysfunction-associated steatotic liver disease progression by exerting dual regulation on HIF-1α
肠道IL-33通过对HIF-1α的双重调控,促进微生物群来源的三甲胺N-氧化物合成,并驱动代谢功能障碍相关的脂肪肝疾病进展。
期刊:Hepatology
影响因子:15.8
doi:10.1097/HEP.0000000000000985
Hai, Suping; Li, Xitang; Xie, Erliang; Wu, Wenhui; Gao, Qiang; Yu, Binghui; Hu, Junjian; Xu, Feiyang; Zheng, Xizhe; Zhang, Bin-Hao; Wu, Di; Yan, Weiming; Ning, Qin; Wang, Xiaojing